Nanoceut

Founded: 2000 • Age: 26 yrs
Pharmaceutical contract manufacturing of high-quality products and food supplements is conducted by Nanoceut.

About Nanoceut

Nanoceut is a Healthcare company founded in 2000. Pharmaceutical contract manufacturing of high-quality products and food supplements is conducted by Nanoceut. The company has 48 employees. Its Indian entity Nanoceut Therapeutics Private Limited reported revenue of β‚Ή14.24 Cr. Nanoceut offers products and services including Tablets and Capsules. Its focus areas include Nutraceuticals, Food Supplements, Manufacturing and Pharmaceuticals.

Company details

Nanoceut is recognized as a pharmaceutical contract manufacturing destination that adheres to global standards for quality and reliability. It is noted for its focus on producing high-quality pharmaceutical products and food supplements, supported by state-of-the-art facilities and a commitment to stringent quality control systems. The companys vision of advancing pharmaceutics to enhance human lives is pursued through efficient processes and innovative technologies, while maintaining core values like accountability and integrity. Partnerships are fostered to meet customer needs effectively, with an emphasis on on-time delivery and continuous improvement in operations.

Key Metrics
  • Indian entity revenue
    ₹14.24 Cr

    FY 2025 · -11% YoY

  • Indian entity net profit
    ₹73.1 Lakh

    FY 2025 · 5% margin

  • Indian entity EBITDA
    ₹2.48 Cr

    FY 2025 · 17% margin

  • Employee Count
    48

Products & Services of Nanoceut

Nanoceut offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceutical Products

Contract manufacturing of oral solid dosage formulations for tablets is conducted under GMP standards.

Capsules
Pharmaceutical Products

Manufacturing of capsules for β-Lactum, Non β-Lactum, and food supplements is performed with innovative formulations.

Board of directors of Nanoceut Therapeutics Private Limited (Nanoceut)

Nanoceut Therapeutics Private Limited is the primary company behind Nanoceut. The board of Nanoceut Therapeutics Private Limited currently have 2 directors; the longest-serving is Haripriya, appointed in 2014. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Haripriya
DIN 06865961
Director26 May 201412 yrs 5 moNanoceut Therapeutics Private Limited
Krishna Kumar Abboy
DIN 08126915
Managing Director01 Feb 20188 yrs 9 moNanoceut Therapeutics Private Limited

Financials of Nanoceut

Figures of Nanoceut Therapeutics Private Limited, the primary company behind Nanoceut, for FY 2025. Revenue was ₹14.24 Cr (-11% year on year). Net profit was ₹73.1 Lakh (5% margin). EBITDA was ₹2.48 Cr (17% margin). Revenue has grown at a compounded annual rate of -1% over three years and +6% over five years.

  • ₹14.24 CrRevenue · FY 2025 · -11% YoY
  • ₹73.1 LakhNet profit · 5% margin
  • ₹2.48 CrEBITDA · 17% margin
  • ₹2.00 CrPaid-up capital
  • 48Employees (provident fund records)
  • -1%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Nanoceut Therapeutics Private Limited are on its company page.

Premium access

Detailed financial statements for Nanoceut

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nanoceut

Nanoceut was founded in 2000.

Nanoceut has 48 employees.

The primary company behind Nanoceut, Nanoceut Therapeutics Private Limited, reported revenue of β‚Ή14.24 Cr for FY 2025, down 11% year on year.

Nanoceut is recognized as a pharmaceutical contract manufacturing destination that adheres to global standards for quality and reliability. It is noted for its focus on producing high-quality pharmaceutical products and food supplements, supported by state-of-the-art facilities and a commitment to stringent quality control systems. The companys vision of advancing pharmaceutics to enhance human lives is pursued through efficient processes and innovative technologies, while maintaining core values like accountability and integrity. Partnerships are fostered to meet customer needs effectively, with an emphasis on on-time delivery and continuous improvement in operations.

Nanoceut offers Tablets and Capsules.

Nanoceut operates through Nanoceut Therapeutics Private Limited.

The legal entities of Nanoceut currently have 2 directors, including Krishna Kumar Abboy, Haripriya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available